FDA Investigator Muna Algharibeh
Muna Algharibeh has inspections in 3 countries as of 12 Oct 2023. Muna Algharibeh has collaborated with a combinined 2949 experts on various inspections, contributing to compliance and improvement across diverse sectors.
Investigator Details
Number of Inspected Sites:
18
Last Inspection Date:
12 Oct 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
United States of America,
Mexico,
India
Co-Investigator(s):
Alicia M Mozzachio,
Amir Alavi,
Ana P Pineda Zavaleta,
Andrace Lde Yampert,
Andrea D Swingle,
Anna M Brannen,
Ava M Bowman,
Bei Y He,
Benjamin J Smith,
Brian D Nicholson,
Bruce H Mccullough,
Byungja E Marciante,
Calvin K Cook,
Carl A Huffman, III,
Charles I Ann,
Charles L Zhou,
Charles M Spyr,
Cherrie A Zachary,
Christopher D Leach,
Christopher T Middendorf,
Claudia Mperez Kasmarski,
Constantin Y Philopoulos,
Corrine M Carter,
Courtney E Hillier,
Cristina Ausin Moreno, PhD,
Cristina Ausin Moreoo, PhD,
Cynthia Jim, CSO,
Daniel J Gorski,
David A Paterson,
Debara R Reese,
Debara Reese,
Debra I Love,
Denise L Burosh,
Dennis Cantellops Paite,
Dennis E Guilfoyle, PhD,
Diane L Raccasi,
Dina A Tallman,
Donald C Obenhuber, PhD,
Dr. Robert C Horan, MD,
Eboni S Funderburk,
Edwin Jao,
Elizabeth L Loreaux,
Elizabeth Ll Edwards,
Emest F Bizjak,
Emilie E Kahn,
Emily J Orban,
Esther C Broner, PhD,
Gary Durbiel Goldner,
German Rivera,
Herberto Negron Rivera,
Heriberto Negron Rivera,
Hyung Yul Lee,
James A Lane,
James W Plucinski,
Jean Blackston Hill,
Jean Blackstone Hill,
Jeffrey A Sommers,
Jeffrey D Meng,
Jeffrey P Raimondi,
Jennifer A Kemp,
Jon P Antoniou,
Jose Acruz Gonzalez,
Joseph A Piechocki,
Joseph R Strelnik,
Joshua P Wireman,
Joslyn K Brunelle, PhD,
Justin A Boyd,
Karen M Montgomery (KMM),
Kathleen R Jones, PhD,
Kham Phommachanh,
L'oreal F Walker,
Larry K Austin,
Lauren Iacono Connors, PhD,
Lauren N Howard,
Lauren N Smith,
Laurimer Kuilan Torres,
LCDR Sean Byrd,
Leigh Anne Myers,
Lewis K Antwi,
Lianji Jin,
Lindsey M Schwierjohann,
Lisa M Bellows,
Logan T Williams,
Luella J Rossi,
Maria Cruz Fisher,
Maria G Gutierrez Hoffman,
Maria Gutierrez Hoffman, PhD,
Maria I Cruz Fisher,
Matt D Suedkamp,
Meisha R Sampson,
Meisha Waters,
Melina Rodriguez Upton,
Mercy Oyugi,
Merry Christie, PhD,
Michael L Casner,
Michael Shanks, MS,
Michele L Forster, PhD,
Michele L Glendenning,
Michele Perry Williams,
Montgomery Montgomery, Karen M,
Muna Alghribeh,
Myra K Casey,
Nailing Zhang,
Neal D Singletary, PhD,
Neali H Lucas,
Nibin Varghese, MS,
Nicholas L Paulin,
Norman K Starks,
Patricia A Cochran,
Patricia H Dlugosz,
Patrick B Cummings,
Patsy J Domingo,
Philip F Istafanos, DMV, MS,
Qiao Y Bobo,
Rabia Ballica, PhD,
Rafael Nevarez Nieves,
Rafeeq A Habeeb,
Ramesh Potla, PhD,
Raymond T Oji,
Reba A Gates,
Rebecca E Dombrowski,
Richard T Riggie,
Riley C Myers, PhD,
Robert Barbosa,
Robert D Tollefsen,
Robert J Ham,
Robert M Barbosa,
Rong Wang, PhD,
Russell K Riley,
Sandra A Boyd,
Sangeeta M Khurana, PhD,
Sara M Onyango,
Sargum C Sood,
Scott R Nichols, PhD,
Sean R Bryd,
Sneha S Patel,
Steven Fong, MS, PhD,
Steven P Eastham,
Susan F Laska, MS,
Susan P Bruederle,
Suyang Qin,
Teresa K Kastner,
Thomas J Arista,
Thuy T Nguyen, LCDR,
Timothy J Schmidt,
Tina M Pawlowski,
Tracey L Harris,
Tracy Denison, PhD,
Vaishali J Patel,
Wayne D Mcgrath,
Wayne E Seifert,
Wendy G Tan, PhD,
William D Tingley,
Yangmin Ning,
Yanming An, PhD,
Yumi J Hiramine
Muna Algharibeh's Documents
| Publish Date | Document Type | Title |
|---|---|---|
| October, 2023 | FDA 483 | PANACEA BIOTEC PHARMA LIMITED - Form 483, 2023-10-12 |
| February, 2022 | FDA 483 | COOK BIOTECH INCORPORATED - Form 483, 2022-02-11 |
| September, 2022 | FDA 483 | Catalent Indiana, LLC - Form 483, 2022-09-01 |
| March, 2021 | FDA 483 Response | Eli Lilly and Company - Form 483R, 2021-04-06 |
| June, 2021 | EIR | Sentry BioPharma Services - EIR, 2021-06-29 |
| March, 2021 | FDA 483 | Eli Lilly and Company - Form 483, 2021-03-16 |
| September, 2022 | EIR | Catalent Indiana, LLC - EIR, 2022-09-01 |
| April, 2022 | FDA 483 | Accugen Laboratories, Inc. - Form 483, 2022-04-22 |
| March, 2022 | FDA 483 | MD Logistics, LLC - Form 483, 2022-03-04 |
| August, 2021 | FDA 483 | Ceela Naturals - Form 483, 2021-08-31 |
| May, 2022 | FDA 483 | Resilience US, Inc. - Form 483, 2022-05-25 |
| May, 2022 | FDA 483 | Resilience US, Inc. - Form 483, 2022-05-25 |
Experience Redica System's NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more